Autolus Therapeutics (AUTL) Goodwill & Intangibles (2018 - 2025)
Autolus Therapeutics posted quarterly Goodwill & Intangibles of $19.8 million for Q4 2025, up 60.1% year-on-year from $12.4 million in Q4 2024, and down 2.34% on a QoQ basis from $20.3 million in Q3 2025.
Autolus Therapeutics (AUTL) has 7 years of Goodwill & Intangibles data on file, last reported at $19.8 million in Q4 2025.
- For the quarter ending Q4 2025, Goodwill & Intangibles rose 60.1% year-over-year to $19.8 million; the trailing twelve-month figure through Dec 2025 stood at $19.8 million (up 60.1% YoY), and the FY2025 full-year result was $19.8 million, up 60.1% from the prior year.
- Goodwill & Intangibles for Q4 2025 stood at $19.8 million, down from $20.3 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $20.3 million in Q3 2025 and bottomed at $8000.0 in Q3 2022.
- The 4-year median for Goodwill & Intangibles is $123500.0 (2021), against an average of $6.5 million.
- The widest annual swing landed in 2022, when Goodwill & Intangibles tumbled 90.8%; it then surged 60.1% in 2025.
- A 4-year view of Goodwill & Intangibles shows it stood at $65000.0 in 2021, then slumped by 87.69% to $8000.0 in 2022, then jumped by 154562.5% to $12.4 million in 2024, then soared by 60.1% to $19.8 million in 2025.
- The last three Goodwill & Intangibles figures came in at $19.8 million (Q4 2025), $20.3 million (Q3 2025), and $12.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.81 Mn |
| Sep 30, 2025 | 20.28 Mn |
| Jun 30, 2025 | 12.93 Mn |
| Mar 31, 2025 | 12.48 Mn |
| Dec 31, 2024 | 12.37 Mn |
| Sep 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 25,000.00 |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 65,000.00 |
| Sep 30, 2021 | 87,000.00 |
| Jun 30, 2021 | 112,000.00 |
| Mar 31, 2021 | 135,000.00 |
| Dec 31, 2020 | 158,000.00 |
| Sep 30, 2020 | 172,000.00 |
| Jun 30, 2020 | 186,000.00 |
| Mar 31, 2020 | 214,000.00 |
| Dec 31, 2019 | 254,000.00 |
| Sep 30, 2018 | 399,000.00 |